v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue    
Total revenue $ 22,936 $ 16,532
Cost of revenue 3,250 1,526
Gross profit 19,686 15,006
Operating expenses:    
Research and development 14,457 11,862
Sales and marketing 8,530 6,529
General and administrative 5,415 4,323
Acquisition related costs 584 0
Total operating expenses 28,986 22,714
Loss from operations (9,300) (7,708)
Interest expense (38) (48)
Other income (expense), net 670 718
Loss before income taxes and loss from equity method investment (8,668) (7,038)
Loss from equity method investment, net of tax 2,989 815
Loss before income taxes (11,657) (7,853)
Provision for (benefit from) income taxes (3,698) 268
Net loss $ (7,959) $ (8,121)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.17) $ (0.20)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.17) $ (0.20)
Weighted-average shares used in computing per share amounts, basic (in shares) 45,544,682 40,853,048
Weighted-average shares used in computing per share amounts, basic (in shares) 45,544,682 40,853,048
Licensing, support and maintenance    
Revenue    
Total revenue $ 19,272 $ 15,335
Variable royalties    
Revenue    
Total revenue 2,503 1,167
Professional services and other    
Revenue    
Total revenue $ 1,161 $ 30